Research Summary

Dr. Na is a pediatric and adult neuro-oncologist at the UCSF Brain Tumor Center and one of the few specialists in the country with an active practice treating both pediatric and adult brain and spinal cord tumors. He serves as Co-Director of the UCSF Comprehensive Neurofibromatosis Center, a Children's Tumor Foundation-designated Comprehensive NF-1 and Schwannomatosis Center and a full member of the Neurofibromatosis Clinical Trials Consortium (NFCTC).

His research focuses on translational and clinical studies in neurofibromatosis and schwannomatosis, working to advance novel discoveries from the laboratory into clinical practice through clinical trials. With expertise in both pediatric and adult neuro-oncology, he is also dedicated to optimizing survivorship for pediatric neuro-oncology patients and improving care for adults with traditionally pediatric neuro-oncologic conditions.

Dr. Na earned his bachelor's degree in History and Science from Harvard College and his medical degree from Drexel University College of Medicine. He completed his pediatrics residency at Case Western Reserve University and a pediatric hematology/oncology fellowship at UCLA. Inspired by his patients, he pursued further training, earning a Ph.D. in Molecular and Medical Pharmacology at UCLA through the prestigious STAR Program, followed by an additional fellowship in adult neuro-oncology at UCLA.

Education

06/2024 - Adult Neuro-Oncology, UCLA Medical Center
Ph.D., 06/2024 - Molecular and Medical Pharmacology, University of California, Los Angeles
06/2021 - Pediatric Hematology/Oncology, UCLA Mattel Children's Hospital
06/2018 - Pediatrics, Rainbow Babies and Children's Hospital
M.D., 05/2015 - Medicine, Drexel University College of Medicine
A.B., 06/2009 - History and Science, Harvard University

Selected Publications

  1. Pan S, Mirchia K, Payne E, Liu SJ, Al-Adli N, Peeran Z, Shukla P, Young JS, Gupta R, Wu J, Pak J, Ozawa T, Na B, Reddy AT, Braunstein SE, Phillips JJ, Chang S, Solomon DA, Perry A, Raleigh DR, Berger MS, Abate AR, Vasudevan HN. Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma. View on PubMed
  2. Na B, Shah SR, Vasudevan HN. Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors. Curr Oncol Rep. 2024 Oct; 26(10):1223. View on PubMed
  3. Na B, Haist B, Shah SR, Sabiston G, Jonas SJ, Vitte J, Wirz RE, Giovannini M. Cold Atmospheric Plasma Induces Growth Arrest and Apoptosis in Neurofibromatosis Type 1-Associated Peripheral Nerve Sheath Tumor Cells. View on PubMed
  4. Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, Church A, Davidoff A, Desai AV, DuBois S, Fair D, Farinhas J, Harrison D, Huang F, Iskander P, Kreissman S, Macy M, Na B, Pashankar F, Pendyala P, Pinto N, Polites S, Rabah R, Shimada H, Slatnick L, Sokol E, Twist C, Vo K, Watt T, Wolden S, Zage P, Schonfeld R, Hang L. Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 08; 22(6):413-433. View on PubMed
  5. Na B, Shah SR, Vasudevan HN. Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors. Curr Oncol Rep. 2024 Jun; 26(6):706-713. View on PubMed
  6. Na B, Shah S, Nghiemphu PL. Cancer Predisposition Syndromes in Neuro-oncology. View on PubMed
  7. Na B, Wang AC, Watterson CT, Martinez-Agosto J, Saitta S, Dutra-Clarke M, Bhansali F, Pineles SL, Chang VY, Shah VS, de Blank P. An unusual presentation of bilateral optic pathway glioma in Crouzon Syndrome. View on PubMed
  8. Peeters SM, Muftuoglu Y, Na B, Daniels DJ, Wang AC. Pediatric Gliomas: Molecular Landscape and Emerging Targets. View on PubMed
  9. Mukamal KJ, Na B, Mu L, Mantzoros CS, Manning WJ, Mittleman MA. Lessons and Challenges from a 6-Month Randomized Pilot Study of Daily Ethanol Consumption: Research Methodology and Study Design. View on PubMed
  10. Panagiotou G, Mu L, Na B, Mukamal KJ, Mantzoros CS. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. View on PubMed

Go to UCSF Profiles, powered by CTSI